AGelity Biomechanics

AGelity Biomechanics is a private orthopedic medical device company developing implant-based treatments for knee cartilage damage and early osteoarthritis. The company was founded as a spin-out from Hospital for Special Surgery and is focused on helping patients with injury-induced osteoarthritis intervene earlier, potentially delaying or avoiding total joint replacement. Its lead technology, AGelity-OCI, is a non-degradable osteochondral/cartilage repair implant designed to provide cartilage integration, immediate stability, and functional load-bearing after implantation. The company appears to be an early-stage venture-backed business operating in the orthopedic life sciences and medtech segment rather than a traditional drug-development biotech.